nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adaptive laboratory evolution of Vibrio cholerae to doxycycline associated with spontaneous mutation
|
Narendrakumar, Lekshmi |
|
|
56 |
3 |
p. |
artikel |
2 |
Addressing the challenges in antisepsis: focus on povidone iodine
|
Barreto, Ruben |
|
|
56 |
3 |
p. |
artikel |
3 |
Antibiotic route and duration of therapy for cellulitis: data extracted from a multi-center clinical trial
|
Williams, O. Martin |
|
|
56 |
3 |
p. |
artikel |
4 |
A pharmacological perspective of chloroquine in SARS-CoV-2 infection: An old drug for the fight against a new coronavirus?
|
Oscanoa, Teodoro J. |
|
|
56 |
3 |
p. |
artikel |
5 |
Are corticosteroids or end-stage renal failure associated with an afebrile presentation of Gram-negative bacteraemia?
|
Even dar, Razi |
|
|
56 |
3 |
p. |
artikel |
6 |
Assessment of the in vitro activity of ceftazidime/avibactam against a global collection of multidrug-resistant Klebsiella spp. from the INFORM surveillance programme (2015–2017)
|
Rossolini, Gian Maria |
|
|
56 |
3 |
p. |
artikel |
7 |
Ceftazidime-avibactam in the treatment of infections caused by KPC-producing Klebsiella pneumoniae: factors associated with clinical efficacy in a single-center cohort
|
Castón, Juan José |
|
|
56 |
3 |
p. |
artikel |
8 |
Chloroquine and hydroxychloroquine in coronavirus disease 2019 (COVID-19). Facts, fiction and the hype: a critical appraisal
|
Khuroo, Mohammad Sultan |
|
|
56 |
3 |
p. |
artikel |
9 |
Comparative activity of ozenoxacin and other quinolones in Staphylococcus aureus strains overexpressing the efflux pump-encoding genes mepA and norA
|
López, Y. |
|
|
56 |
3 |
p. |
artikel |
10 |
Comparative assessment of the effects of bumped kinase inhibitors on early zebrafish embryo development and pregnancy in mice
|
Anghel, Nicoleta |
|
|
56 |
3 |
p. |
artikel |
11 |
Dalbavancin and telavancin in the treatment of infective endocarditis: a literature review
|
Lampejo, Temi |
|
|
56 |
3 |
p. |
artikel |
12 |
Diagnostic performance of initial blood urea nitrogen combined with D-dimer levels for predicting in-hospital mortality in COVID-19 patients
|
Cheng, Anying |
|
|
56 |
3 |
p. |
artikel |
13 |
Dissemination of a ‘rare’ extended-spectrum β-lactamase gene bla SFO-1 mediated by epidemic clones of carbapenemase-producing Enterobacter hormaechei in China
|
Zhou, Kai |
|
|
56 |
3 |
p. |
artikel |
14 |
Erratum to ``A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence'' [International Journal of Antimicrobial Agents 55/6 (2020) 105948]
|
Wang, Lisheng |
|
|
56 |
3 |
p. |
artikel |
15 |
4-Ethoxybenzoic acid inhibits Staphylococcus aureus biofilm formation and potentiates biofilm sensitivity to vancomycin
|
Campbell, Mariya |
|
|
56 |
3 |
p. |
artikel |
16 |
Identification of mobile colistin resistance genes (mcr-1.1, mcr-5 and mcr-8.1) in Enterobacteriaceae and Alcaligenes faecalis of human and animal origin, Nigeria
|
Ngbede, Emmanuel O. |
|
|
56 |
3 |
p. |
artikel |
17 |
Impact of comorbidities on the performance of interferon-gamma release assay in an elderly Greek population without overt immunodeficiency
|
Tsilika, Maria |
|
|
56 |
3 |
p. |
artikel |
18 |
In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection
|
Braz, Helyson Lucas Bezerra |
|
|
56 |
3 |
p. |
artikel |
19 |
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page
|
|
|
|
56 |
3 |
p. |
artikel |
20 |
In vitro activity of ceftazidime-avibactam against Gram-negative isolates collected in 18 European countries, 2015–2017
|
Stone, Gregory G |
|
|
56 |
3 |
p. |
artikel |
21 |
In vitro activity of olorofim (F901318) against fungi of the genus, Scedosporium and Rasamsonia as well as against Lomentospora prolificans, Exophiala dermatitidis and azole-resistant Aspergillus fumigatus
|
Kirchhoff, Lisa |
|
|
56 |
3 |
p. |
artikel |
22 |
Lactoferrin as potential preventative and adjunct treatment for COVID-19
|
Chang, Raymond |
|
|
56 |
3 |
p. |
artikel |
23 |
No evidence of SARS-CoV-2 circulation before identification of the first Swiss SARS-CoV-2 case
|
Lhopitallier, Loïc |
|
|
56 |
3 |
p. |
artikel |
24 |
Personalised antimicrobial dosing: standing on the shoulders of giants
|
Wallenburg, Eveline |
|
|
56 |
3 |
p. |
artikel |
25 |
Pharmacodynamics of immune response biomarkers of interest for evaluation of treatment effects in bacterial infections
|
Thorsted, Anders |
|
|
56 |
3 |
p. |
artikel |
26 |
Pharmacokinetics and safety of posaconazole intravenous solution and powder for oral suspension in children with neutropenia: an open-label, sequential dose-escalation trial
|
Groll, Andreas H. |
|
|
56 |
3 |
p. |
artikel |
27 |
Recommendations for use of a hydroxychloroquine loading dose in patients with COVID-19
|
Kara, Emre |
|
|
56 |
3 |
p. |
artikel |
28 |
Repurposing of host-based therapeutic agents for the treatment of coronavirus disease 2019 (COVID-19): a link between antiviral and anticancer mechanisms?
|
Alonso, Daniel F. |
|
|
56 |
3 |
p. |
artikel |
29 |
Ribavirin therapy for severe COVID-19: a retrospective cohort study
|
Tong, Song |
|
|
56 |
3 |
p. |
artikel |
30 |
Synergism of sophoraflavanone G with norfloxacin against effluxing antibiotic-resistant Staphylococcus aureus
|
Sun, Zhong-Lin |
|
|
56 |
3 |
p. |
artikel |
31 |
Ticarcillin and piperacillin adsorption on to polyethersulfone haemodiafilter membranes in an ex-vivo circuit
|
Economou, Caleb J.P. |
|
|
56 |
3 |
p. |
artikel |
32 |
Title Page & Editorial Board
|
|
|
|
56 |
3 |
p. |
artikel |
33 |
Tocilizumab for severe COVID-19: a systematic review and meta-analysis
|
Lan, Shao-Huan |
|
|
56 |
3 |
p. |
artikel |
34 |
Treatment of osteoarticular, cardiovascular, intravascular-catheter-related and other complicated infections with dalbavancin and oritavancin: A systematic review
|
Thomas, Geren |
|
|
56 |
3 |
p. |
artikel |
35 |
Virological patterns of hepatitis C virus patients with failure to the current-generation direct-acting antivirals
|
Pisaturo, M. |
|
|
56 |
3 |
p. |
artikel |
36 |
Voriconazole topical cream formulation: evidence for stability and antifungal activity
|
Bouchand, Camille |
|
|
56 |
3 |
p. |
artikel |